The impact of BVDV infection on adaptive immunity

Biologicals

Volumn 41, Issue 1, 2013, Pages 52-60

  Chase, Christopher C L ^a  

^a SOUTH DAKOTA STATE UNIVERSITY   (United States)

Author keywords

Adaptive immune response; B lymphocytes; BVDV; Dendritic cells; Gamma delta T cells; T lymphocytes

Indexed keywords

B7 ANTIGEN; BOVINE DIARRHEA VIRUS VACCINE; CD28 ANTIGEN; CD86 ANTIGEN; GAMMA INTERFERON; GLYCOPROTEIN E2; INTERLEUKIN 12; INTERLEUKIN 2; MATERNAL ANTIBODY; NEUTRALIZING ANTIBODY; NONSTRUCTURAL PROTEIN 2; NONSTRUCTURAL PROTEIN 3; PATTERN RECOGNITION RECEPTOR; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG; VIRUS ANTIBODY; VIRUS ANTIGEN; VIRUS VACCINE;

ADAPTIVE IMMUNITY; ANTIBODY RESPONSE; ANTIGEN PRESENTATION; ARTICLE; BOVINE DIARRHEA VIRUS; BOVINE VIRAL DIARRHEA; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CROSS PROTECTION; CYTOKINE RESPONSE; CYTOTOXIC T LYMPHOCYTE; GAMMA DELTA T LYMPHOCYTE; IMMUNOSTIMULATION; IN VITRO STUDY; IN VIVO STUDY; INNATE IMMUNITY; NONHUMAN; PERSISTENT INFECTION; PHAGOCYTOSIS; PRIORITY JOURNAL; T CELL DEPLETION; TH1 CELL; VACCINATION; VIRUS INTERFERENCE; VIRUS STRAIN; VIRUS VIRULENCE;

ADAPTIVE IMMUNITY; ANIMALS; ANTIGEN PRESENTATION; BOVINE VIRUS DIARRHEA-MUCOSAL DISEASE; CATTLE; CYTOKINES; CYTOPATHOGENIC EFFECT, VIRAL; DIARRHEA VIRUSES, BOVINE VIRAL; HOST-PATHOGEN INTERACTIONS; MODELS, IMMUNOLOGICAL; T-LYMPHOCYTES; TOLL-LIKE RECEPTORS;

ANIMALIA; BOVINE VIRAL DIARRHEA VIRUS 1;

EID: 84872164593     PISSN: 10451056     EISSN: 10958320     Source Type: Journal    
DOI: 10.1016/j.biologicals.2012.09.009     Document Type: Article

References (82)

1. Brackenbury L.S., Carr B.V., Charleston B. Aspects of the innate and adaptive immune responses to acute infections with BVDV. Vet Microbiol 2003, 96:337-344.
2. Chase C.C.L., Elmowalid G., Yousif A.A.A. The immune response to bovine viral diarrhea virus: a constantly changing picture. Vet Clin North Am Food Anim Pract 2004, 20:95-114.
3. Lambot M., Douart A., Joris E., Letesson J.J., Pastoret P.P. Characterization of the immune response of cattle against non-cytopathic and cytopathic biotypes of bovine viral diarrhoea virus. J Gen Virol 1997, 78:1041-1047.
4. Lambot M., Joris E., Douart A., Lyaku J., Letesson J.J., Pastoret P.P. Evidence for biotype-specific effects of bovine viral diarrhoea virus on biological responses in acutely infected calves. J Gen Virol 1998, 79:27-30.
5. Spagnuolo-Weaver M., Allan G.M., Kennedy S., Foster J.C., Adair B.M. Distribution of cytopathic and noncytopathic bovine viral diarrhea virus antigens in tissues of calves following acute experimental infection. J Vet Diagn Invest 1997, 9:287-297.
6. Medzhitov R. Toll-like receptors and innate immunity. Nat Immunol 2001, 1:235-245.
7. Coffey T.J., Werling D. Therapeutic targeting of the innate immune system in domestic animals. Cell Tissue Res 2011, 343:251-261.
8. Jungi T.W., Farhat K., Burgener I.A., Werling D. Toll-like receptors in domestic animals. Cell Tissue Res 2011, 343:107-120.
9. Hennessy E.J., Parker A.E., O'Neil L.A.J. Targeting toll-like receptors: emerging therapeutics?. Nat Rev Drug Discov 2010, 9:293-307.
10. Borish L.C., Steinke J.W. 2.Cytokines and chemokines. J Allergy Clin Immunol 2003, 111:S460-S475.
11. Borish L.C., Steinke J.W. 3.Cytokines and chemokines. J Allergy Clin Immunol 2006, 117:S441-S445.
12. Glew E.J., Carr B.V., Brackenbury L.S., Hope J.C., Charleston B., Howard C.J. Differential effects of bovine viral diarrhoea virus on monocytes and dendritic cells. J Gen Virol 2003, 84:1771-1780.
13. Lee S.R., Pharr G.T., Boyd B.L., Pinchuk L.M. Bovine viral diarrhea viruses modulate toll-like receptors, cytokines and co-stimulatory molecules genes expression in bovine peripheral blood monocytes. Comp Immunol Microbiol Infect Dis 2008, 31:403-418.
14. Welsh M.D., Adair B.M., Foster J.C. Effect of BVD virus infection on alveolar macrophage functions. Vet Immunol Immunopathol 1995, 46:195-210.
15. Adler B., Adler H., Pfeister H., Jungi T.W., Peterhans E. Macrophages infected with cytopathic bovine viral diarrhea virus release a factor(s) capable of priming uninfected macrophages for activation-induced apoptosis. J Virol 1997, 71:3255-3258.
16. Lee S.R., Nanduri B., Pharr G.T., Stokes J.V., Pinchuk L.M. Bovine viral diarrhea virus infection affects the expression of proteins related to professional antigen presentation in bovine monocytes. Biochem Biophys Acta 2009, 1794:14-22.
17. Archambault D., Beliveau C., Couture Y., Carman S. Clinical response and immunomodulation following experimental challenge of calves with type 2 noncytopathogenic bovine viral diarrhea virus. Vet Res 2000, 31:215-227.
18. Ellis J.A., Davis W.C., Belden E.L., Pratt D.L. Flow cytofluorimetric analysis of lymphocyte subset alterations in cattle infected with bovine viral diarrhea virus. Vet Pathol 1988, 25:231-236.
19. Brodersen B.W., Kelling C.L. Alteration of leukocyte populations in calves concurrently infected with bovine respiratory syncytial virus and bovine viral diarrhea virus. Viral Immunol 1999, 12:323-334.
20. Ridpath J.F., Neill J.D., Peterhans E. Impact of variation in acute virulence of BVDV1 strains on design of better vaccine efficacy challenge models. Vaccine 2007, 25:8058-8066.
21. Ganheim C., Johannisson A., Ohagen P., Persson K. Changes in peripheral blood leucocyte counts and subpopulations after experimental infection with BVDV and/or Mannheimia haemolytica. J Vet Med B Infect Dis Vet Public Health 2005, 52:380-385.
22. Silflow R.M., Degel P.M., Harmsen A.G. Bronchoalveolar immune defense in cattle exposed to primary and secondary challenge with bovine viral diarrhea virus. Vet Immunol Immunopathol 2005, 103:129-139.
23. Teichmann U., Liebler-Tenorio E., Pohlenz J.F. Ultrastructural changes in follicles of small-intestinal aggregated lymphoid nodules in early and advanced phases of experimentally induced mucosal disease in calves. Am J Vet Res 2000, 61:174-182.
24. Liebler-Tenorio E.M., Ridpath J.F., Neill J.D. Lesions and tissue distribution of viral antigen in severe acute versus subclinical acute infection with BVDV2. Biologicals 2003, 31:119-122.
25. Liebler-Tenorio E.M., Ridpath J.F., Neill J.D. Distribution of viral antigen and development of lesions after experimental infection with highly virulent bovine viral diarrhea virus type 2 in calves. Am J Vet Res 2002, 63:1575-1584.
26. Stoffregen B., Bolin S.R., Ridpath J.F., Pohlenz J. Morphologic lesions in type 2 BVDV infections experimentally induced by strain BVDV2-1373 recovered from a field case. Vet Microbiol 2000, 77:157-162.
27. Liebler-Tenorio E.M., Ridpath J.F., Neill J.D. Distribution of viral antigen and development of lesions after experimental infection of calves with a BVDV 2 strain of low virulence. J Vet Diagn Invest 2003, 15:221-232.
28. Liebler-Tenorio E.M., Ridpath J.F., Neill J.D. Distribution of viral antigen and tissue lesions in persistent and acute infection with the homologous strain of noncytopathic bovine viral diarrhea virus. J Vet Diagn Invest 2004, 16:388-396.
29. Howard C.J., Clarke M.C., Sopp P., Brownlie J. Immunity to bovine virus diarrhoea virus in calves: the role of different T-cell subpopulations analyzed by specific depletion in vivo with monoclonal antibodies. Vet Immunol Immunopathol 1992, 32:303-314.
30. Liang R., Van Den Hurk J.V., Landi A., Lawman Z., Deregt D., Townsend H., et al. DNA prime-protein boost strategies protect cattle from bovine viral diarrhea virus type 2 challenge. J Gen Virol 2008, 89:453-466.
31. =4 T-cell responses to bovine viral diarrhoea virus in cattle. Virus Res 2000, 67:67-80.
32. + T-cell recognition of a heterologous virus by cattle persistently infected with bovine viral diarrhea virus. Virology 2000, 276:70-82.
33. +4 T cells reactive with bovine diarrhoea virus. Vet Immunol Immunopathol 2002, 87:235-238.
34. Rhodes S.G., Cocksedge J.M., Collins R.A., Morrison W.I. Differential cytokine responses of CD4+ and CD8+ T cells in response to bovine viral diarrhea virus in cattle. J Gen Virol 1999, 80:1673-1679.
35. Waldvogel A.S., Hediger-Withaler B.M., Eicher R., Zakher A., Zarlenga D.S., Gasbarre L.C., et al. Interferon-γ and interleukin-4 mRNA expression by peripheral blood mononuclear cells from pregnant and non-pregnant cattle seropositive for bovine viral diarrhea virus. Vet Immunol Immunopathol 2000, 77:201-212.
36. Graham S.P., Haines F.J., Johns H.L., Sosan O., La Rocca S.A., Lamp B., et al. Characterisation of vaccine-induced, broadly cross-reactive IFN-γ secreting T cell responses that correlate with rapid protection against classical swine fever virus. Vaccine 2012, 30:2742-2748.
37. Burciaga-Robles L.O., Step D.L., Krehbiel C.R., Holland B.P., Richards C.J., Montelongo M.A., et al. Effects of exposure to calves persistently infected with bovine viral diarrhea virus type 1b and subsequent infection with Mannheima haemolytica on clinical signs and immune variables: model for bovine respiratory disease via viral and bacterial interaction. J Anim Sci 2010, 88:2166-2178.
38. Hou L., Wilkerson M., Kapil S., Mosier D., Shuman W., Reddy J.R., et al. The effect of different viral diarrhea virus genotypes and biotypes on the metabolic activity and activation status of bovine peripheral blood mononuclear cells. Viral Immunol 1998, 11:233-244.
39. Charleston B., Hope J.C., Carr B.V., Howard C.J. Masking of two in vitro immunological assays for Mycobacterium bovis (BCG) in calves acutely infected with non-cytopathic bovine viral diarrhoea virus. Vet Rec 2001, 149:481-484.
40. Beer M., Wolf G., Pichler A., Wolfmeyer A. Cytotoxic T-lymphocyte responses in cattle infected with bovine viral diarrhea virus. Vet Microbiol 1997, 58:9-22.
41. Hegde N., Srikumaran S. The use of bovine MHC class I allele-specific peptide motifs and proteolytic cleavage specificities for the prediction of potential cytotoxic T lymphocyte epitopes of bovine viral diarrhea virus. Virus Genes 1997, 14:111-121.
42. Jutila M.A., Holderness J., Graff J.C., Hedges J.F. Antigen-independent priming: a transitional response of bovine γδ T-cells to infection. Anim Health Res Rev 2008, 9:47-57.
43. Bruschke C.J.M., Haghparast A., Hoek A., Rutten V.P., Wentink G.H., Van Rijn P.A., et al. The immune response of cattle, persistently infected with noncytopathic BVDV, after superinfection with antigentically semi-homologous cytopathic BVDV. Vet Immunol Immunopathol 1998, 62:37-50.
44. Pedrera M., Sanchez-Cordon P.J., Romero-Trevejo J.L., Risalde M.A., Greiser-Wilke I., Nunez A., et al. Morphological changes and virus distribution in the ileum of colostrum-deprived calves inoculated with non-cytopathic bovine viral diarrhoea virus genotype-1. J Comp Pathol 2009, 141:52-62.
45. Pedrera M., Gomez-Villamandos J.C., Romero-Trevejo J.L., Risalde M.A. Apoptosis in lymphoid tissues of calves inoculated with non-cytopathic bovine viral diarrhea virus genotype 1: activation of effector caspase-3 and role of macrophages. J Gen Virol 2009, 90:2650-2659.
46. Ridpath J.F., Bendfeldt S., Neill J.D., Liebler-Tenorio E. Lymphocytopathogenic activity in vitro correlates with high virulence in vivo for BVDV type 2 strains: criteria for a third biotype of BVDV. Virus Res 2006, 118:62-69.
47. Bendfeldt D., Ridpath J.F., Neill J.D. Activation of cell signaling pathways is dependant on the biotype of bovine viral diarrhea viruses type 2. Virus Res 2007, 126:96-105.
48. Donis R.O. Molecular biology of BVDV and its interaction with the host. Vet Clin North Am Food Anim Pract 1995, 11:393-423.
49. Donis R.O., Dubovi E.J. Molecular specificity of the antibody responses of cattle naturally infected and experimentally infected with cytopathic and noncytopathic bovine viral diarrhea virus biotypes. Am J Vet Res 1987, 48:1549-1554.
50. Van Rijn P.A. A common neutralizing epitope on envelope glycoprotein E2 of different pestiviruses: implications for improvement of vaccines and diagnostics for classical swine fever (CSF)?. Vet Microbiol 2007, 125:150-156.
51. Deregt D., Van Rijn P.A., Wiens T.Y., Van Den Hurk J. Monoclonal antibodies to the E2 protein of a new genotype (type 2) of bovine viral diarrhea virus define three antigenic domains involved in neutralization. Virus Res 1998, 57:171-181.
52. Deregt D., Bolin S.R., Van Den Hurk J., Ridpath J.F., Gilbert S.A. Mapping of a type 1-specific and a type-common epitope on the E2 (gp53) protein of bovine viral diarrhea virus with neutralization escape mutants. Virus Res 1998, 53:81-90.
53. Vilcek S. Identification of pestiviruses contaminating cell lines and fetal calf sera. Acta Virol 2001, 45:81-86.
54. Hill K.L., Hunsaker B.D., Townsend H.G., Van Drunen Little-Van Den Hurk S., Griebel P.J. Mucosal immune response in newborn Holstein calves that had maternally derived antibodies and were vaccinated with an intranasal multivalent modified-live virus vaccine. J Am Vet Med Assoc 2012, 240:1231-1240.
55. Potgieter L.N. Immunology of bovine viral diarrhea virus. Vet Clin North Am Food Anim Pract 1995, 11:501-520.
56. Nobiron I., Thompson I., Brownlie J., Collins M.E. DNA vaccination against bovine viral diarrhoea virus induces humoral and cellular responses in cattle with evidence for protection against viral challenge. Vaccine 2003, 21:2082-2092.
57. Chase C.C., Chase S.K., Fawcett L. Trends in the BVDV serological response in the upper midwest. Biologicals 2003, 31:145-151.
58. Fredriksen B., Sandvik T., Loken T., Odegaard S.A. Level and duration of serum antibodies in cattle infected experimentally and naturally with bovine virus diarrhoea virus. Vet Rec 1999, 144:111-114.
59. Hamers C., Di Valentin E., Lecomte C., Lambot M., Joris E., Genicot B., et al. Virus neutralizing antibodies against a panel of 18 BVDV isolates in calves vaccinated with Rispoval RS-BVD. J Vet Med B Infect Dis Vet Public Health 2000, 47:721-726.
60. Cortese V.S., Whittaker R., Ellis J., Ridpath J.F., Bolin S.R. Specificity and duration of neutralizing antibodies induced in healthy cattle after administration of a modified-live virus vaccine against bovine viral diarrhea. Am J Vet Res 1998, 59:848-850.
61. Hamers C., Di Valentin E., Lecomte C., Lambot M., Joris E., Genicot B., et al. Virus neutralizing antibodies against a 22 bovine isolates in vaccinated calves. Vet J 2002, 163:61-67.
62. Jones L., Van Campen H., Zu Z.C., Schnackel J.A. Comparison of neutralizing antibodies to type 1a, 1b and 2 bovine viral diarrhea virus from experimentally infected and vaccinated cattle. Bov Pract 2001, 35:137-140.
63. Fulton R.W., Ridpath J.F., Saliki J.T., Briggs R.E., Confer A.W., Burge L.J., et al. Bovine viral diarrhea virus (BVDV) 1b: predominant BVDV subtype in calves with respiratory disease. Can J Vet Res 2002, 66:181-190.
64. Fulton R.W., Ridpath J.F., Confer A.W., Saliki J.T., Burge L.J., Payton M.E. Bovine viral diarrhoea virus antigenic diversity: impact on disease and vaccination programmes. Biologicals 2003, 31:89-95.
65. Reber A.J., Tanner M., Okinaga T., Woolums A.R., Williams S., Ensley D.T., et al. Evaluation of multiple immune parameters after vaccination with modified live or killed bovine viral diarrhea virus vaccines. Comp Immunol Microbiol Infect Dis 2006, 29:61-77.
66. Fulton R.W., Burge L.J. Bovine viral diarrhea virus types 1 and 2 antibody response in calves receiving modified live virus or inactivated vaccines. Vaccine 2001, 19:264-274.
67. Becher P., Alvalos Ramirez R., Orlich M., Cedillo Rosales S., Konig M., Schweizer M., Stalder H., et al. Genetic and antigenic characterization of novel pestivirus genotypes: implications for classification. Virology 2003, 311:96-104.
68. Bachofen C., Stadler H., Braun U., Hilbe M., Ehrensperger F., Peterhans E. Co-existence of genetically and antigenically diverse bovine viral diarrhoea viruses in an endemic situation. Vet Microbiol 2008, 131:93-102.
69. Brewoo J.N., Haase C.J., Sharp P., Schultz R.D. Leukocyte profile of cattle persistently infected with bovine viral diarrhea virus. Vet Immunol Immunopathol 2007, 115:369-374.
70. Piccinini R., Luzzago C., Frigerio M., Frigerio V., Liandris E., Zecconi A. Comparison of blood non-specific immune parameters in bovine virus diarrhoea virus (BVDV) persistently infected and in immune heifers. J Vet Med B Infect Dis Vet Public Health 2006, 53:62-67.
71. Larsson B., Fossum C., Alenius S. A cellular analysis of immunosuppression in cattle with mucosal disease. Res Vet Sci 1988, 44:71-75.
72. Glew E.J., Howard C.J. Antigen-presenting cells from calves persistently infected with bovine diarrhoea virus, a member of the Flaviviridae, are not compromised in their ability to present viral antigen. J Gen Virol 2001, 82:1677-1685.
73. Collins M.E., Desport M., Brownlie J. Bovine viral diarrhea quasispecies during persistent infection. Virology 1999, 259:85-98.
74. Fray M.D., Supple E.A., Morrison W.I., Charleston B. Germinal center localization of bovine viral diarrhoea virus in persistently infected animals. J Gen Virol 2000, 81:1669-1673.
75. Fulton R.W., Step D.L., Ridpath J.F., Saliki J.T., Confer A.W., Johnson B.J., et al. Response of calves persistently infected with noncytopathic bovine viral diarrhea virus (BVDV) subtype 1b after vaccination with heterologous BVDV strains in modified live virus vaccines and Mannheimia haemolytica bacterin-toxoid. Vaccine 2003, 21:2980-2985.
76. Endsley J.J., Ridpath J.F., Neill J.D., Sandbulte M.R., Roth J.A. Induction of T lymphocytes specific for bovine viral diarrhea virus in calves with maternal antibody. Viral Immunol 2004, 17:13-23.
77. Platt R., Widel P.W., Kesl L.D., Roth J.A. Comparison of humoral and cellular immune responses to a pentavalent modified live virus vaccine in three age groups of calves with maternal antibodies, before and after BVDV type 2 challenge. Vaccine 2009, 27:4508-4519.
78. Ridpath J.F., Neill J.D., Endsley J.J., Roth J.A. Effect of passive immunity on the development of a protective immune response against bovine viral diarrhea virus in calves. Am J Vet Res 2003, 64:65-69.
79. Ellis J., West K., Cortese V., Konoby C., Weigel D. Effect of maternalantibodies on induction and persistence of vaccine-induced immune responses against bovine viral diarrhea virus type II in young calves. J Am Vet Med Assoc 2001, 219:351-356.
80. Zimmerman A.D., Boots R.E., Valli J.L., Chase C.C.L. Evaluation of protection against virulent bovine viral diarrhea virus type 2 in calves that had maternal antibodies and were vaccinated with a modified-live vaccine. J Am Vet Med Assoc 2006, 228:1749-1753.
81. Zimmerman A.D., Buterbaugh R.E., Schnackel J.A., Chase C.C.L. Efficacy of a modified live virus vaccine administered to calves with maternal antibodies and challenged seven months later with a virulent bovine viral diarrhea type 2 virus. Bov Pract 2009, 43:35-43.
82. Stevens E.T., Brown M.S., Burdett W.W., Bolton M.W., Nordstrom S.T., Chase C.C.L. Efficacy of a non-adjuvanted, modified-live virus vaccine in calves with maternal antibodies against a virulent bovine viral diarrhea virus type 2a challenge seven months following vaccination. Bov Pract 2011, 45:23-31.